PL2010012T3 - Zastosowanie wyciągu z szafranu jako środka nasycającego do leczenia nadwagi - Google Patents

Zastosowanie wyciągu z szafranu jako środka nasycającego do leczenia nadwagi

Info

Publication number
PL2010012T3
PL2010012T3 PL07731932T PL07731932T PL2010012T3 PL 2010012 T3 PL2010012 T3 PL 2010012T3 PL 07731932 T PL07731932 T PL 07731932T PL 07731932 T PL07731932 T PL 07731932T PL 2010012 T3 PL2010012 T3 PL 2010012T3
Authority
PL
Poland
Prior art keywords
saffron
overweight
extract
treatment
satiety agent
Prior art date
Application number
PL07731932T
Other languages
English (en)
Inventor
Cédric Bourges
Original Assignee
Cédric Bourges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cédric Bourges filed Critical Cédric Bourges
Publication of PL2010012T3 publication Critical patent/PL2010012T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/115—Natural spices, flavouring agents or condiments; Extracts thereof obtained by distilling, stripping, or recovering of volatiles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL07731932T 2006-04-25 2007-04-23 Zastosowanie wyciągu z szafranu jako środka nasycającego do leczenia nadwagi PL2010012T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0651443A FR2900053B1 (fr) 2006-04-25 2006-04-25 Utilisation du safranal, de la crocine, de la picrocrocine et leurs derives en tant qu'agent de satiete pour le traitement de la surcharge ponderale
EP07731932.5A EP2010012B1 (fr) 2006-04-25 2007-04-23 Utilisation d'un extrait de safran en tant qu'agent de satiété pour le traitement de la surcharge pondérale

Publications (1)

Publication Number Publication Date
PL2010012T3 true PL2010012T3 (pl) 2017-07-31

Family

ID=37575309

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07731932T PL2010012T3 (pl) 2006-04-25 2007-04-23 Zastosowanie wyciągu z szafranu jako środka nasycającego do leczenia nadwagi

Country Status (12)

Country Link
US (3) US20100028464A1 (pl)
EP (1) EP2010012B1 (pl)
JP (3) JP2009534452A (pl)
AU (1) AU2007245501B2 (pl)
CA (1) CA2648985C (pl)
DK (1) DK2010012T3 (pl)
ES (1) ES2616128T3 (pl)
FR (1) FR2900053B1 (pl)
HU (1) HUE031843T2 (pl)
PL (1) PL2010012T3 (pl)
PT (1) PT2010012T (pl)
WO (1) WO2007125243A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2995185A1 (fr) * 2012-09-13 2014-03-14 Mundema Nouvelle composition a base de safranal
FR3004110B1 (fr) * 2013-04-03 2016-03-18 Green Plants Extracts Composition pour lutter contre le stress
US20150017278A1 (en) * 2013-07-09 2015-01-15 Carlton R. Branker Method for weight loss and management and herbal composition for achieving the same
JP5929937B2 (ja) 2014-01-30 2016-06-08 トヨタ自動車株式会社 組電池および組電池の接続切換方法
FR3017799B1 (fr) * 2014-02-24 2017-02-10 Constant Thomaoglou Composition comestiblepour le traitement de la phase de debut du syndrome depressif
BE1021980B1 (fr) * 2014-05-20 2016-02-01 Dyna + Sarl Composition amincissante.
LU92458B1 (fr) * 2014-05-20 2015-11-23 Dyna Sarl Composition amincissante
ES2573542B1 (es) * 2016-04-18 2017-03-13 Pharmactive Biotech Products, S.L. Empleo de un nuevo extracto de azafrán para la prevención de trastornos del estado de ánimo relacionados con la depresión
CN105902511A (zh) * 2016-06-01 2016-08-31 汇美农业科技有限公司 一种藏红花素泡腾片及其制备方法
FR3054443B1 (fr) * 2016-07-28 2020-01-03 Activ'inside Extrait de plante tres concentre en safranal, procede d'obtention et utilisations
EP3697389B1 (en) * 2017-10-16 2025-08-20 Council of Scientific and Industrial Research Sustained release formulations of crocus sativus
BE1026707B1 (fr) * 2018-10-15 2020-05-18 Asfar Extrait de safran liquide, complement alimentaire sous forme liquide enrichi en safranal et boisson
IT201900002457A1 (it) * 2019-02-20 2020-08-20 Neuraxpharm Italy S P A Composizione per prevenire e trattare sintomi depressivi e cognitivi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0633795B2 (ja) 1987-05-22 1994-05-02 株式会社東芝 扇風機の首振装置
JPH07135936A (ja) * 1993-11-17 1995-05-30 Yoshihide Hagiwara サフラン飲料
JPH09202730A (ja) * 1996-01-24 1997-08-05 Nippon Mektron Ltd 発ガン抑制作用剤
JPH11302149A (ja) 1998-04-15 1999-11-02 Pola Chem Ind Inc メラニン産生抑制剤及びそれを含有する皮膚外用剤
US6306430B1 (en) * 1998-04-16 2001-10-23 The Iams Company Process for decreasing adiposity using vitamin a as a dietary supplement
JP2001333778A (ja) * 2000-05-26 2001-12-04 Akihiko Shiraishi グルコキナーゼ活性化物質、糖尿病治療薬及び抗肥満薬
JP4100911B2 (ja) * 2002-01-11 2008-06-11 一丸ファルコス株式会社 グルタミン酸デカルボキシラーゼ活性化剤
AU2003211636A1 (en) * 2002-03-04 2003-09-16 The Nisshin Oillio Group, Ltd Body temperature elevating agents
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
CA2534523A1 (en) * 2003-09-03 2005-03-10 Unilever Plc Satiety enhancing food compositions
JP6190573B2 (ja) 2012-04-12 2017-08-30 大成プラス株式会社 ノック式浸透印面スタンプ

Also Published As

Publication number Publication date
JP6093425B2 (ja) 2017-03-08
US20180104299A1 (en) 2018-04-19
CA2648985C (fr) 2012-06-19
EP2010012A1 (fr) 2009-01-07
FR2900053A1 (fr) 2007-10-26
JP2014015480A (ja) 2014-01-30
FR2900053B1 (fr) 2012-11-16
AU2007245501A1 (en) 2007-11-08
HUE031843T2 (en) 2017-08-28
US20110236481A1 (en) 2011-09-29
JP2009534452A (ja) 2009-09-24
CA2648985A1 (fr) 2007-11-08
WO2007125243A1 (fr) 2007-11-08
ES2616128T3 (es) 2017-06-09
JP2016053062A (ja) 2016-04-14
DK2010012T3 (en) 2017-03-06
US9833489B2 (en) 2017-12-05
AU2007245501B2 (en) 2012-12-13
EP2010012B1 (fr) 2016-11-30
PT2010012T (pt) 2017-02-22
US20100028464A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
PT2010012T (pt) Utilização de um extrato de açafrão como agente de saciedade para o tratamento do excesso de peso
IL248204A0 (en) Combined treatment of tumors expressing 38cd
EP2317845A4 (en) METHOD FOR TREATING AN OVERWEIGHT OR FATABLE PERSON
IL196465A0 (en) Compositions and methods for the treatment of mucositis
SI2118074T1 (sl) Spojine za preprečevanje in zdravljenje kardiovaskularnih bolezni
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
ZA200907492B (en) Compositions for targeted imaging and therapy
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
PT2101731T (pt) Endoxifeno para utilização no tratamento de cancro
EP2156846A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST DIARRHEA
IL200387A0 (en) Heterocylic compounds, compositions comprising them and methods of their use
IL194826A0 (en) Compositions and methods for cellular imaging and therapy
GB0909297D0 (en) Composition for the treatment of skin conditions
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
EP2213303A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
ZA201007362B (en) Conjugates for the treatment of mesothelioma
IL201119A0 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP2124968A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE ATROPHY
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
GB0723100D0 (en) Treatment of HFnEF
EP2056811A4 (en) MODAFINIL TREATMENT AGAINST EARLY EJACULATION
GB0808730D0 (en) Compositions and methods for the prevention and treatment of schistosomiasis